What mental health condition do SSRIs particularly target?

Selective serotonin reuptake inhibitors (SSRIs) are primarily designed to treat mood disorders, especially major depressive disorder and generalized anxiety disorder. The mechanism of SSRIs involves increasing the levels of serotonin in the brain by inhibiting its reuptake into the presynaptic cell. This increase in serotonin availability is associated with improvements in mood and anxiety, making SSRIs particularly effective for individuals experiencing symptoms of mood disorders.

Mood disorders encompass a range of conditions characterized by the disruption of mood regulation, including depression and bipolar disorder. Since SSRIs directly address the biochemical imbalances thought to contribute to these disorders, they are a first-line treatment option in clinical practice for improving mood and reducing anxiety. While SSRIs can also have an impact on other conditions, their primary indication remains within the scope of mood disorders.